On December 25, 2025, this newsletter featured 5 cluster buys and 2 insider purchases detected from SEC Form 4 filings.
📈 Daily Insider & Cluster Buy Highlights – December 25, 2025
Here are some of the most interesting insider and cluster buying signals from the last 7 days.
⚠️ For information purposes only.
This information is provided for informational purposes only and does not constitute investment advice, financial advice, trading advice, or any other type of advice. All investments carry risk, including the potential loss of principal. Past performance is not indicative of future results. You should consult with a qualified financial advisor, accountant, or other professional before making any investment decisions. The information contained in this newsletter is not intended to be a substitute for professional financial advice.
📊 About Fair Value:
The Fair Value shown for each company is calculated using a Levered Discounted Cash Flow (DCF) model. This method estimates the intrinsic value of a stock by projecting future cash flows and discounting them back to present value, accounting for the company's debt structure. A positive percentage difference indicates the stock may be undervalued relative to this model, while a negative percentage suggests it may be overvalued. Fair value calculations are estimates and should be considered alongside other factors.
🔥 Notable Cluster Buys (≥ $500,000)
$10.31
Current Price
52W: Low: $7.78 | High: $13.64
Participants: 2 insiders
Total Shares: 4,031,496
Total Value: $34,872,440
Timeframe: 0 days
Date Range: Dec 11, 2025 to Dec 11, 2025
👥 Participant Details:
PORTNOY ADAM D.
Director
Date: Dec 11, 2025
2,015,748 shares
$17,436,220
@ $8.65/share
P&L: +19.2% (+$3,346,142)
Tremont Realty Capital LLC
10% Owner
Date: Dec 11, 2025
2,015,748 shares
$17,436,220
@ $8.65/share
P&L: +19.2% (+$3,346,142)
📈
Average P&L: 19.2% ($3,346,142 gain)
Verrica Pharmaceuticals IncView Chart
Ticker: VRCA
$8.33
Current Price
52W: Low: $3.28 | High: $9.82
Participants: 5 insiders
Total Shares: 1,485,584
Total Value: $6,302,590
Timeframe: 0 days
Date Range: Nov 25, 2025 to Nov 25, 2025
👥 Participant Details:
Rosenberg Noah L.
Date: Nov 25, 2025
2,357 shares
$10,000
@ $4.24/share
P&L: +96.3% (+$9,634)
Rieger Jayson
Date: Nov 25, 2025
94,311 shares
$400,114
@ $4.24/share
P&L: +96.3% (+$385,496)
Zawitz David
Date: Nov 25, 2025
10,000 shares
$42,425
@ $4.24/share
P&L: +96.3% (+$40,875)
Kirby John J.
Date: Nov 25, 2025
3,536 shares
$15,001
@ $4.24/share
P&L: +96.3% (+$14,453)
Manning Paul B
Date: Nov 25, 2025
1,375,380 shares
$5,835,050
@ $4.24/share
P&L: +96.3% (+$5,621,866)
📈
Average P&L: 96.3% ($1,214,465 gain)
Analyst Coverage:
Analyst Rating: C
Avg Price Target: $17.00 (+104.1% vs current)
BIMINI CAPITAL MANAGEMENT, INCView Chart
Ticker: BMNM
$2.17
Current Price
52W: Low: $0.60 | High: $2.20
Participants: 4 insiders
Total Shares: 534,495
Total Value: $828,467
Timeframe: 0 days
Date Range: Dec 19, 2025 to Dec 19, 2025
👥 Participant Details:
Dwyer Robert J
Director
Date: Dec 19, 2025
100,000 shares
$155,000
@ $1.55/share
P&L: +40.3% (+$62,450)
Griffith Ashley B
Director
Date: Dec 19, 2025
50,000 shares
$77,500
@ $1.55/share
P&L: +40.3% (+$31,225)
Haas G Hunter IV
Director
Date: Dec 19, 2025
192,247 shares
$297,983
@ $1.55/share
P&L: +40.3% (+$120,058)
Cauley Robert E
Director
Date: Dec 19, 2025
192,248 shares
$297,984
@ $1.55/share
P&L: +40.3% (+$120,059)
📈
Average P&L: 40.3% ($83,448 gain)
Valuation Metrics:
Fair Value: $8.70 (300.1% undervalued vs current price)
Analyst Coverage:
Analyst Rating: B+
📰 Recent News (Last 7 Days):
Defense World • Dec 23, 2025
Shares of Bimini Capital Management Inc. (OTCMKTS:BMNM - Get Free Report) crossed above its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $1.64 and tra...
$4.23
Current Price
52W: Low: $3.09 | High: $8.19
Participants: 2 insiders
Total Shares: 500,000
Total Value: $1,965,990
Timeframe: 1 days
Date Range: Dec 18, 2025 to Dec 19, 2025
👥 Participant Details:
Lau Daniel
10% Owner
Date: Dec 18, 2025
360,000 shares
$1,423,728
@ $3.95/share
P&L: +7.0% (+$99,072)
LM Asset (IM) Inc.
10% Owner
Date: Dec 19, 2025
140,000 shares
$542,262
@ $3.87/share
P&L: +9.2% (+$49,938)
📈
Average P&L: 8.1% ($74,505 gain)
Valuation Metrics:
Fair Value: $111.65 (2539.4% undervalued vs current price)
Analyst Coverage:
Analyst Rating: C-
📰 Recent News (Last 7 Days):
Defense World • Dec 23, 2025
Gran Tierra Energy Inc. (TSE: GTE - Get Free Report) (NYSEMKT:GTE)'s share price crossed below its fifty day moving average during trading on Monday. The stock has a fifty day moving average of C$5.83...
$60.00
Current Price
52W: Low: $52.28 | High: $82.44
Participants: 2 insiders
Total Shares: 58,691
Total Value: $3,448,580
Timeframe: 0 days
Date Range: Dec 22, 2025 to Dec 22, 2025
👥 Participant Details:
COOK TIMOTHY D
Director
Date: Dec 22, 2025
50,000 shares
$2,948,500
@ $58.97/share
P&L: +1.7% (+$51,500)
SWAN ROBERT HOLMES
Director
Date: Dec 22, 2025
8,691 shares
$500,080
@ $57.54/share
P&L: +4.3% (+$21,380)
📈
Average P&L: 3.0% ($36,440 gain)
Valuation Metrics:
Fair Value: $56.94 (5.1% overvalued vs current price)
Analyst Coverage:
Analyst Rating: C-
Avg Price Target: $75.65 (+26.1% vs current)
📊 Recent Earnings: Dec 18, 2025
EPS: $0.53 (est: $0.37)
Revenue: $12,427,000,000M (est: $12,205,298,693M)
💼 Notable Individual Insider Buys (≥ $100,000)
N/A
COOPER COMPANIES, INC ($COO)
Transaction Date: Dec 22, 2025
Shares: 1,784
Purchase Price: $84.06
Purchase Value: $149,963
📉
P&L: 1.8% ($2,658 loss)
Valuation Metrics:
Fair Value: $48.47 (41.3% overvalued vs current price)
Analyst Coverage:
Analyst Rating: B
Avg Price Target: $88.67 (+7.4% vs current)
📰 Recent News (Last 7 Days):
GlobeNewsWire • Dec 23, 2025
SAN RAMON, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today that the Company's Board of Directors (the “Board”) has appointed ...
Zacks Investment Research • Dec 19, 2025
The Cooper Companies, Inc. (COO) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, COO's 50-day simple moving average crossed a...
N/A
Amylyx Pharmaceuticals, Inc ($AMLX)
Transaction Date: Dec 23, 2025
Shares: 8,100
Purchase Price: $12.45
Purchase Value: $100,845
Analyst Coverage:
Analyst Rating: C-
Avg Price Target: $17.50 (+40.1% vs current)
⚠️ For information purposes only.
This information is provided for informational purposes only and does not constitute investment advice, financial advice, trading advice, or any other type of advice. All investments carry risk, including the potential loss of principal. Past performance is not indicative of future results. You should consult with a qualified financial advisor, accountant, or other professional before making any investment decisions. The information contained in this newsletter is not intended to be a substitute for professional financial advice.